Status:
COMPLETED
Nutritional Supplements in Patients with Anorexia Nervosa
Lead Sponsor:
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
12-40 years
Phase:
NA
Brief Summary
Anorexia nervosa causes gastroparesis, constipation, and can lead to elevated liver enzymes. It is often necessary to supplement the diet of patients with nutritional formulas. The ingestion of a pept...
Detailed Description
Main objective: • To compare the digestive tolerance of an oligomeric nutritional supplement with respect to a polymeric nutritional supplement in a group of patients diagnosed with anorexia nervosa ...
Eligibility Criteria
Inclusion
- Male or female participants, ≥ 12 y ≤ 40 years of age at screening
- Diagnosed of Anorexy nervous according to DSM-5
- Appropiate cultural level \& understanding of the clinical study
- To be in agreement in participate voluntarily in the study and written informed consent must be obtained from the participants.
- Females who are non-pregnant and non-lactating women or women who have given birth at least six weeks before to the screening visit.
Exclusion
- Allergy or intolerance to any component of the products under study.
- Participation in a concomitant trial that conflicts with this study
- Doesn't sign the informed consent
Key Trial Info
Start Date :
October 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 22 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05184738
Start Date
October 15 2021
End Date
May 22 2022
Last Update
February 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Regional Universitario de Málaga
Málaga, MALAGA, Spain, 29009